BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33112200)

  • 21. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
    Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.
    Bi Q; Li H; Du J; Li H; Li Q; Wang J; Huang Y; Gong X
    Clin Radiol; 2022 Apr; 77(4):299-306. PubMed ID: 35094817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dentate Nucleus Signal Intensity Changes in Children with Adrenoleukodystrophy in Comparison to Primary Brain Tumor with and without Radiotherapy after Gadobutrol Administration.
    Ozturk K; Nascene D
    J Neuroimaging; 2021 May; 31(3):602-608. PubMed ID: 33783925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
    Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
    Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
    Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
    Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
    Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
    Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
    Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
    Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
    Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
    Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
    Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
    J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.
    Radbruch A; Haase R; Kickingereder P; Bäumer P; Bickelhaupt S; Paech D; Wick W; Schlemmer HP; Seitz A; Bendszus M
    Radiology; 2017 Jun; 283(3):828-836. PubMed ID: 28273007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
    Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
    Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
    Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
    Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
    Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
    Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
    Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
    Hu HH; Pokorney A; Towbin RB; Miller JH
    Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.